Task: Answer the multiple choice question.
Question: Which drug exhibits a -3.856% hERG inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CCn1cc(C2=NOC(C(=O)O)C2)c(C)n1
b.) Cc1nccn1-c1c2c(c(C#N)c3nc4ccccc4n13)CCC2
Answer: b. Cc1nccn1-c1c2c(c(C#N)c3nc4ccccc4n13)CCC2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1nccn1-c1c2c(c(C#N)c3nc4ccccc4n13)CCC2
Cc1nccn1-c1c2c(c(C#N)c3nc4ccccc4n13)CCC2
16-(2-methylimidazol-1-yl)-1,8-diazatetracyclo[7.7.0.02,7.011,15]hexadeca-2,4,6,8,10,15-hexaene-10-carbonitrile